SunRegen is a biopharmaceutical company with a mission to develop drugs to treat neurodegenerative diseases.
Business Model:
Revenue: $2M
Employees: 11-50
Address: Gewerbestrasse 24
City: Allschwil
State: basel-country
Zip: 4123
Country: CH
SunRegen is a biopharmaceutical company with a mission to develop drugs to treat neurodegenerative diseases. They focus on innovative treatments for patients suffering from neurological, neuromuscular and ophthalmic diseases. Their first product candidates in development target primary optical atrophy. They are further evaluating them for use in serious neurological / neuromuscular diseases such as ALS, Huntington&s;s, Alzheimer’s and Parkinson’s disease. Their team is composed of passionate and innovative founders and experts who have solid track records in drug development and clinical research in multinational pharmaceutical companies or management experience in international technology enterprises. Their determination in bringing life-changing treatments to patients encompasses everything they do.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2018 | Grant | 1 | $83.3k |
EASME - EU Executive Agency for SMEs EASME - EU Executive Agency for SMEs |
3/2019 | Series A | 1 | - |
GoBeyond GoBeyond |
3/2019 | Series A | 1 | - |
GoBeyond GoBeyond |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|